Drug Markets/Rivaroxaban

Rivaroxaban

35 NDCs across 12 manufacturers|20 Generic,15 Brand

Rivaroxaban is used to treat pulmonary embolism and venous thrombosis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Jul 1, 2011, and the first generic was approved Mar 3, 2025. FDA's Orange Book lists 67 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $6.2 billion on Rivaroxaban across 6.7 million claims for 1.3 million beneficiaries.

Rivaroxaban is available as 35 NDCs from 12 manufacturers (20 generic, 15 brand), with NADAC prices from $0.60 to $19.54 per EA — the most expensive product costs about 33× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

35

20G / 15B

Manufacturers

12

competing in market

Price Spread

$0.60 – $19.54

per EA, 33 of 35 NDCs

7d Activity

8↑27↓0 flat

avg -2.4% WoW · of 35 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

35 NDCs total, 35 shown

WatchDrug ↕Price 7d Change ↕
XARELTO 15 MG TABLET
$19.5402
per EA
+0.03%
XARELTO 15 MG TABLET
$19.5402
per EA
+0.03%
XARELTO 15 MG TABLET
$19.5402
per EA
+0.03%
XARELTO 20 MG TABLET
$19.5375
per EA
-0.01%
XARELTO 20 MG TABLET
$19.5375
per EA
-0.01%
XARELTO 20 MG TABLET
$19.5375
per EA
-0.01%
XARELTO 20 MG TABLET
$19.5375
per EA
-0.01%
XARELTO 10 MG TABLET
$19.5228
per EA
+0.02%
XARELTO 10 MG TABLET
$19.5228
per EA
+0.02%
XARELTO 10 MG TABLET
$19.5228
per EA
+0.02%
XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK
$19.4782
per EA
+0.04%
XARELTO 2.5 MG TABLET
$9.7719
per EA
-0.04%
XARELTO 2.5 MG TABLET
$9.7719
per EA
-0.04%
XARELTO 2.5 MG TABLET
$9.7719
per EA
-0.04%
XARELTO 1 MG/ML SUSPENSION
$3.7628
per ML
+0.03%
RIVAROXABAN 1 MG/ML SUSPENSION
$1.7993
per ML
-0.77%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%
RIVAROXABAN 2.5 MG TABLET
$0.5989
per EA
-4.41%

Frequently Asked Questions

What is Rivaroxaban used to treat?

Rivaroxaban is used to treat pulmonary embolism and venous thrombosis, per the National Library of Medicine's MED-RT classification.

When did Rivaroxaban become available as a generic?

FDA approved the first generic Rivaroxaban (ANDA) on Mar 3, 2025. The Orange Book currently lists 67 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Rivaroxaban?

In 2024, Medicare Part D spent $6.2 billion on Rivaroxaban across 6.7 million claims for 1.3 million beneficiaries.

How many Rivaroxaban products are on the market?

The Rivaroxaban drug market contains 35 NDCs from 12 manufacturers — 20 generic and 15 brand products.

What is the price range for Rivaroxaban?

NADAC reference prices for Rivaroxaban range from $0.5989 to $19.5402 per EA — the most expensive product costs about 33× the cheapest. 2 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.

Is generic Rivaroxaban cheaper than brand?

The average generic NADAC for Rivaroxaban is $0.5989 per EA, versus $17.4381 for brand-labeled products — brand versions average about 29× the generic price.

Which manufacturers make Rivaroxaban?

12 manufacturers list Rivaroxaban in NADAC. Ranked by number of NDCs, the largest are Janssen Pharmaceuticals Inc. (15), Florida Pharmaceutical Products, LLC (2), Exelan Pharmaceuticals Inc. (2), Macleods Pharmaceuticals Limited (2), Dr. Reddy's Laboratories Inc. (2).

How has the price of Rivaroxaban changed recently?

Over the past 7 days, 8 Rivaroxaban NDCs rose and 27 fell, with a market-wide average change of -2.4%.